Bochtler, T., Hegenbart, U., Granzow, M., Seckinger, A., Kimmich, C., Goldschmidt, H., . . . Schönland, S. (2015). Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens. Journal of clinical oncology, 33(12), . https://doi.org/10.1200/JCO.2014.57.4947
Chicago-Zitierstil (17. Ausg.)Bochtler, Tilmann, et al. "Translocation T(11;14) Is Associated with Adverse Outcome in Patients with Newly Diagnosed AL Amyloidosis When Treated with Bortezomib-based Regimens." Journal of Clinical Oncology 33, no. 12 (2015). https://doi.org/10.1200/JCO.2014.57.4947.
MLA-Zitierstil (9. Ausg.)Bochtler, Tilmann, et al. "Translocation T(11;14) Is Associated with Adverse Outcome in Patients with Newly Diagnosed AL Amyloidosis When Treated with Bortezomib-based Regimens." Journal of Clinical Oncology, vol. 33, no. 12, 2015, https://doi.org/10.1200/JCO.2014.57.4947.